Notas de prensa

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2

Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2

IBM and ETH Zurich join forces to shape the future of algorithms for the AI and quantum era

IBM and ETH Zurich join forces to shape the future of algorithms for the AI and quantum era

TeamViewer Surpasses One Million AI Sessions in Major Adoption Milestone

BH Macro Limited - Net Asset Value(s)

SOFTSWISS Unveils Second Barrichello × Sparco Capsule: Driven by Ambition

CES 2026 Audit Shows Four Percent Growth in Participation as Innovators Showed Up in Las Vegas

Una auditoría de CES 2026 revela un crecimiento del cuatro por ciento en la participación

La auditoría de la CES 2026 muestra un crecimiento del 4 % en la participación, gracias a la presencia de innovadores en Las Vegas